BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 18062776)

  • 1. Can rodent models of diabetic kidney disease clarify the significance of early hyperfiltration?: recognizing clinical and experimental uncertainties.
    Levine DZ
    Clin Sci (Lond); 2008 Jan; 114(2):109-18. PubMed ID: 18062776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes-induced hyperfiltration in adenosine A(1)-receptor deficient mice lacking the tubuloglomerular feedback mechanism.
    Sällström J; Carlsson PO; Fredholm BB; Larsson E; Persson AE; Palm F
    Acta Physiol (Oxf); 2007 Jul; 190(3):253-9. PubMed ID: 17581137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathogenicity of glomerular hyperfiltration, a question of glomerular tolerance?].
    Wüstenberg PW; Dabels J
    Z Gesamte Inn Med; 1990 Apr; 45(8):210-4. PubMed ID: 2198716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperfiltration, nitric oxide, and diabetic nephropathy.
    Levine DZ
    Curr Hypertens Rep; 2006 May; 8(2):153-7. PubMed ID: 16672149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney function in early diabetes: the tubular hypothesis of glomerular filtration.
    Thomson SC; Vallon V; Blantz RC
    Am J Physiol Renal Physiol; 2004 Jan; 286(1):F8-15. PubMed ID: 14656757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in susceptibility to develop parameters of diabetic nephropathy in four mouse strains with type 1 diabetes.
    Franzén S; Friederich-Persson M; Fasching A; Hansell P; Nangaku M; Palm F
    Am J Physiol Renal Physiol; 2014 May; 306(10):F1171-8. PubMed ID: 24623147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lowering of proteinuria in response to antihypertensive therapy predicts improved renal function in late but not in early diabetic nephropathy: a pooled analysis.
    Jerums G; Panagiotopoulos S; Premaratne E; Power DA; MacIsaac RJ
    Am J Nephrol; 2008; 28(4):614-27. PubMed ID: 18285683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerular hyperfiltration in type 1 diabetes mellitus results from primary changes in proximal tubular sodium handling without changes in volume expansion.
    Vervoort G; Veldman B; Berden JH; Smits P; Wetzels JF
    Eur J Clin Invest; 2005 May; 35(5):330-6. PubMed ID: 15860045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production.
    Prabhakar S; Starnes J; Shi S; Lonis B; Tran R
    J Am Soc Nephrol; 2007 Nov; 18(11):2945-52. PubMed ID: 17928507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic COX inhibition reduces diabetes-induced hyperfiltration, proteinuria, and renal pathological markers in 36-week B6-Ins2(Akita) mice.
    Nasrallah R; Robertson SJ; Hébert RL
    Am J Nephrol; 2009; 30(4):346-53. PubMed ID: 19609076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse models of diabetic nephropathy.
    Breyer MD; Böttinger E; Brosius FC; Coffman TM; Harris RC; Heilig CW; Sharma K;
    J Am Soc Nephrol; 2005 Jan; 16(1):27-45. PubMed ID: 15563560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of PPARgamma in renoprotection in Type 2 diabetes: molecular mechanisms and therapeutic potential.
    Yang J; Zhang D; Li J; Zhang X; Fan F; Guan Y
    Clin Sci (Lond); 2009 Jan; 116(1):17-26. PubMed ID: 19037881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glomerular filtration rate in early diabetes: ongoing discussions of causes and mechanisms.
    Frische S
    J Nephrol; 2011; 24(5):537-40. PubMed ID: 21887674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anemia in diabetic nephropathy: prevalence, clinical and pathophysiological aspects].
    Shestakova MV; Martynov SA; Il'in AV; Kniazeva AP; Shamkhalova MSh; Trubitsyna NP
    Ter Arkh; 2008; 80(6):41-7. PubMed ID: 18655475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy.
    Hohenstein B; Hugo CP; Hausknecht B; Boehmer KP; Riess RH; Schmieder RE
    Nephrol Dial Transplant; 2008 Apr; 23(4):1346-54. PubMed ID: 18065828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early detection and treatment of diabetic nephropathy.
    Woredekal Y
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():999-1004. PubMed ID: 18806717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glomerulo-tubular balance in diabetes mellitus: molecular evidence and clinical consequences].
    Evangelista C; Rizzo M; Cantone A; Corbo G; Di Donato L; Trocino C; Zacchia M; Capasso G
    G Ital Nefrol; 2006; 23 Suppl 34():S16-20. PubMed ID: 16633989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of glomerular hyperfiltration in the initiation and progression of diabetic nephropathy.
    Brenner BM; Hostetter TH; Olson JL; Rennke HG; Venkatachalam MA
    Acta Endocrinol Suppl (Copenh); 1981; 242():7-10. PubMed ID: 6940408
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pathophysiologic mechanisms of early changes in renal hemodynamics in diabetes mellitus].
    Komers R
    Cas Lek Cesk; 1996 Mar; 135(5):135-9. PubMed ID: 8681353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.